furosemide has been researched along with Osteoarthritis in 13 studies
Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.
Osteoarthritis: A progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The research objective was to evaluate the differential anti-inflammatory and chondroprotective efficacy of a simulated digest of indomethacin and a commercially available herbal product in a cartilage model of osteoarthritis." | 3.74 | Differential anti-inflammatory and chondroprotective effects of simulated digests of indomethacin and an herbal composite (Mobility) in a cartilage explant model of articular inflammation. ( Lindinger, MI; Orth, MW; Pearson, W, 2007) |
| " Therefore this observational study over 6 months should evaluate patterns of treatments like mono- or combinations therapy, dosage and safety during long-term treatment under pragmatic conditions with the aqueous willow bark extract STW 33-I, (Proaktiv(®); drug-extract-ratio 16-23:1)." | 2.78 | Willow bark extract STW 33-I in the long-term treatment of outpatients with rheumatic pain mainly osteoarthritis or back pain. ( Kelber, O; Melzer, J; Müller, J; Stange, R; Uehleke, B, 2013) |
| " Adverse effects appear to be minimal as compared to non-steroidal anti-inflammatory drugs including aspirin." | 2.52 | Efficacy and Safety of White Willow Bark (Salix alba) Extracts. ( Shara, M; Stohs, SJ, 2015) |
| "Osteoarthritis affects 1 % of the world's population and is the most common cause of musculoskeletal impairment in the elderly." | 1.43 | Brazilian oral herbal medication for osteoarthritis: a systematic review protocol. ( Bergamaschi, Cde C; Bhatnaga, N; Biavatti, MW; Busse, JW; Kennedy, SA; Lopes, LC; Moura, Mdel G; Wang, L, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (46.15) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rosario, M | 1 |
| Song, SX | 1 |
| McCullough, LD | 1 |
| Clark, P | 1 |
| Rowland, SE | 1 |
| Denis, D | 1 |
| Mathieu, MC | 1 |
| Stocco, R | 1 |
| Poirier, H | 1 |
| Burch, J | 1 |
| Han, Y | 1 |
| Audoly, L | 1 |
| Therien, AG | 1 |
| Xu, D | 1 |
| Del Grossi Moura, M | 1 |
| Lopes, LC | 2 |
| Biavatti, MW | 2 |
| Kennedy, SA | 2 |
| de Oliveira E Silva, MC | 1 |
| Silva, MT | 1 |
| de Cássia Bergamaschi, C | 1 |
| Henrotin, Y | 1 |
| Mobasheri, A | 1 |
| Uehleke, B | 1 |
| Müller, J | 1 |
| Stange, R | 1 |
| Kelber, O | 1 |
| Melzer, J | 1 |
| Moreau, M | 1 |
| Lussier, B | 1 |
| Pelletier, JP | 1 |
| Martel-Pelletier, J | 1 |
| Bédard, C | 1 |
| Gauvin, D | 1 |
| Troncy, E | 1 |
| Shara, M | 1 |
| Stohs, SJ | 1 |
| Moura, Mdel G | 1 |
| Busse, JW | 1 |
| Wang, L | 1 |
| Bhatnaga, N | 1 |
| Bergamaschi, Cde C | 1 |
| Chrubasik, S | 2 |
| Pollak, S | 1 |
| Black, A | 1 |
| Biegert, C | 1 |
| Wagner, I | 1 |
| Lüdtke, R | 1 |
| Kötter, I | 1 |
| Lohmüller, C | 1 |
| Günaydin, I | 1 |
| Taxis, K | 1 |
| Heide, L | 1 |
| Saller, R | 1 |
| Pearson, W | 1 |
| Orth, MW | 1 |
| Lindinger, MI | 1 |
3 reviews available for furosemide and Osteoarthritis
| Article | Year |
|---|---|
Oral herbal medicines marketed in Brazil for the treatment of osteoarthritis: A systematic review and meta-analysis.
Topics: Boswellia; Brazil; Curcuma; Harpagophytum; Herbal Medicine; Humans; Osteoarthritis; Phytotherapy; Pl | 2017 |
Natural Products for Promoting Joint Health and Managing Osteoarthritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Biological Products; Boswellia; Chondroitin; Curcumin; Diet | 2018 |
Efficacy and Safety of White Willow Bark (Salix alba) Extracts.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Benzyl Alcohols; Flavonoids; Glucosides; Humans; NF-k | 2015 |
3 trials available for furosemide and Osteoarthritis
| Article | Year |
|---|---|
Willow bark extract STW 33-I in the long-term treatment of outpatients with rheumatic pain mainly osteoarthritis or back pain.
Topics: Adult; Aged; Aged, 80 and over; Analgesics; Antirheumatic Agents; Back Pain; Female; Humans; Male; M | 2013 |
A medicinal herb-based natural health product improves the condition of a canine natural osteoarthritis model: a randomized placebo-controlled trial.
Topics: Analysis of Variance; Ananas; Animals; Boswellia; Curcuma; Dog Diseases; Dogs; Harpagophytum; Locomo | 2014 |
Efficacy and safety of willow bark extract in the treatment of osteoarthritis and rheumatoid arthritis: results of 2 randomized double-blind controlled trials.
Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheu | 2004 |
7 other studies available for furosemide and Osteoarthritis
| Article | Year |
|---|---|
An unusual case of stroke.
Topics: Antihypertensive Agents; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diuretics; Female; Furo | 2012 |
MF498 [N-{[4-(5,9-Diethoxy-6-oxo-6,8-dihydro-7H-pyrrolo[3,4-g]quinolin-7-yl)-3-methylbenzyl]sulfonyl}-2-(2-methoxyphenyl)acetamide], a selective E prostanoid receptor 4 antagonist, relieves joint inflammation and pain in rodent models of rheumatoid and os
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Cell | 2008 |
Brazilian oral herbal medication for osteoarthritis: a systematic review protocol.
Topics: Boswellia; Brazil; Cat's Claw; Chenopodium ambrosioides; Cordia; Curcuma; Fabaceae; Harpagophytum; H | 2016 |
Willow bark extract, a useful alternative for the treatment of osteoarthritis: comment on the editorial by Marcus and Suarez-Almazor.
Topics: Humans; Osteoarthritis; Plant Bark; Plant Extracts; Salix | 2003 |
Effects of willow bark extract and therapeutic activity.
Topics: Cyclooxygenase 2; Humans; Isoenzymes; Membrane Proteins; Osteoarthritis; Plant Bark; Plant Extracts; | 2003 |
[Interview with Professor Dr. Reinhard Saller, Zurich University Hospital. Willow bark extract--more than a natural alternative in antirheumatic therapy?].
Topics: Antioxidants; Antirheumatic Agents; Arthralgia; Back Pain; Humans; Osteoarthritis; Phytotherapy; Pla | 2005 |
Differential anti-inflammatory and chondroprotective effects of simulated digests of indomethacin and an herbal composite (Mobility) in a cartilage explant model of articular inflammation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cartilage, Articular; Dinoprostone; Dose-Response | 2007 |